Literature DB >> 7432401

Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention.

J P Davis, P J Chesney, P J Wand, M LaVenture.   

Abstract

Surveillance for toxic-shock syndrome (TSS) in Wisconsin detected 38 cases with onsets from September 1975 through June 1980. Thirty-seven of the cases occurred after January 1, 1979; 37 of the patients were women, 35 cases occurred during menses; 38 patients were white; and one patient died. Cervical or vaginal cultures were obtained before antibiotic therapy in 23 patients, and 17 cultures were positive for Staphylococcus aureus. Ten patients had at least one recurrent episode during subsequent menstrual periods. The recurrence rate was lower in patients who had been treated with beta-lactamase-resistant antibiotics. Thirty-five patients were matched for age and menstruation to 105 controls: 34 of 35 cases (versus 80 of 105 controls) used tampons during every menstrual period (P < 0.01); nine of 35 cases (versus 64 of 105 controls) practiced contraception (P < 0.001). In Wisconsin the minimum incidence of TSS as defined by clinical criteria is 6.2 cases per 100,000 menstruating women per year. The rate of TSS among menstruating women younger than 30 years was 2.4 to 3.3 times the rate among those who were 30 or older.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7432401     DOI: 10.1056/NEJM198012183032501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  112 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

3.  Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens.

Authors:  R J Stuyt; M G Netea; S H Kim; D Novick; M Rubinstein; B J Kullberg; J W Van der Meer; C A Dinarello
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

Review 5.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 6.  Toxic shock syndrome: a review of the literature.

Authors:  D Thomas; P S Withington
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

7.  Toxic shock syndrome in Utah--1976 to 1983.

Authors:  J A Jacobson; C R Nichols; E M Kasworm
Journal:  West J Med       Date:  1985-09

8.  Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.

Authors:  J C de Azavedo; T J Foster; P J Hartigan; J P Arbuthnott; M O'Reilly; B N Kreiswirth; R P Novick
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.

Authors:  R N Robbins; R F Reiser; G L Hehl; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 10.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.